Aztreonam is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please sign in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Gram-negative bacterial pneumonia
- Skin and soft tissue infections (caused by Gram-negative bacilli)
- Complicated and uncomplicated urinary tract infections
- Intra-abdominal infections (in combination with metronidazole)
- Septicemia (cause by Gram-negative bacilli)
- Gynecologic infections (in combination with anaerobic coverage)
- Nebulized aztreonam is indicated for treatment of respiratory symptoms in cystic fibrosis (CF patients with FEV1 of 25-75% of predicted) with P. aeruginosa
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Alternative therapy for treatment of Gram-negative infections in patients with severe allergies
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
Last updated: June 3, 2017
Citation
TY - ELEC
T1 - Aztreonam
ID - 540041
A1 - Avdic,Edina,Pharm.D.
AU - Pham,Paul,Pharm.D.
Y1 - 2017/06/03/
PB - Johns Hopkins ABX Guide
UR - https://www.unboundmedicine.com/medline/view/Johns_Hopkins_ABX_Guide/540041/all/Aztreonam
ER -